Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

DR info

Clinical trials : 11 / Drugs : 20 - (DrugBank : 7) / Drug target genes : 20 - Drug target pathways : 13

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

4,5-dichloro-1,3-benzenedisulphonamide
   University of Rochester
      2010   Phase 3   EUCTR2008-002306-19-GB   United Kingdom
Acetazolamide
   University of Rochester
      2008   Phase 1   NCT00839501   United Kingdom;United States
Bumetanide
   University College of London
      2014   Phase 2   EUCTR2013-004195-36-GB   United Kingdom
   University College, London
      2015   Phase 2   NCT02582476   United Kingdom
DCP
   University of Rochester
      2010   Phase 3   EUCTR2008-002306-19-GB   United Kingdom
Dichlorphenamide
   National Center for Research Resources (NCRR)
      1992   Phase 3   NCT00004802   -
   University of Rochester
      2010   Phase 3   EUCTR2008-002306-19-GB   United Kingdom
      2007   Phase 3   NCT00494507   Canada;France;Italy;United Kingdom;United States
Flecainide + BETA-blocker
   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
      2025   Phase 2   NCT06205550   -
Idebenone
   Xuanwu Hospital, Capital University of Medical Sciences
      2017   Phase 4   ChiCTR-IPR-17010316   China
Lamotrigin actavis
   Grete Andersen
      2013   -   EUCTR2013-003309-24-DK   Denmark
Lamotrigin ”nordic prime 100 MG
   Rigshospitalet, department of Neurology
      2022   Phase 3   EUCTR2021-003784-94-DK   Denmark
Lamotrigin ”nordic prime 25 MG
   Rigshospitalet, department of Neurology
      2022   Phase 3   EUCTR2021-003784-94-DK   Denmark
Lamotrigin ”nordic prime 50 MG
   Rigshospitalet, department of Neurology
      2022   Phase 3   EUCTR2021-003784-94-DK   Denmark
Lamotrigine
   Grete Andersen
      2013   -   EUCTR2013-003309-24-DK   Denmark
   Grete Andersen, MD
      2013   Phase 3   NCT01939561   Denmark
   Rigshospitalet, department of Neurology
      2022   Phase 3   EUCTR2021-003784-94-DK   Denmark
Mexiletine
   Rigshospitalet, department of Neurology
      2022   Phase 3   EUCTR2021-003784-94-DK   Denmark
Namuscla
   Rigshospitalet, department of Neurology
      2022   Phase 3   EUCTR2021-003784-94-DK   Denmark
Potassium
   University of Rochester
      2008   Phase 1   NCT00839501   United Kingdom;United States